• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对 SARS-CoV2 阳性患者中枢神经系统受累及其表现的系统评价。

Systemic review of CNS involvement and its manifestations in SARS-CoV2 positive patients.

机构信息

Department of Neurology, UP University of Medical Sciences, Saifai, Etawah, UP, India.

Department of Community Medicine, UP University of Medical Sciences, Saifai, Etawah, UP, India.

出版信息

J Infect Public Health. 2021 Jun;14(6):734-739. doi: 10.1016/j.jiph.2021.03.005. Epub 2021 Mar 23.

DOI:10.1016/j.jiph.2021.03.005
PMID:34020214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7986314/
Abstract

Coronavirus is known to cause various systemic infections both in human and animal which are mostly mild in nature. However, recent years have seen major pandemics caused by coronavirus which are very invasive and virulent in nature. The recent SARS-CoV2 is a new addition to this list of coronavirus pandemics. So the present study was done to systematically review the CNS involvement and its manifestations in SARS-CoV2 positive patients. Systemic review of article published between 1st Dec 2019 to 31st July 2020 searched through web-based database of MEDLINE (Pubmed) and Google scholar using following keywords "COVID -19" OR "CORONAVIRUS" OR "SARS-CoV2" AND "NEUROLOGICAL" OR "CNS" OR "BRAIN". Using the steps of systemic review eight article were selected for qualitative analysis. Majority of these article were reporting neurological symptoms among patients admitted in different wards along with others general symptoms. None of the study was specifically devoted to study the neurological manifestations and complications in SARS-CoV2 positive patients. The present study concludes that there is a scarcity of good quality research which attempts to establish the role of SARS-CoV2 infection in CNS and its manifestations. However, there are evidences that CNS involvement is present in majority of the patients. Proper documentation of theses involvement and indentification of these into mild, moderate and severe infection will help in early identification and treatment of these patients.

摘要

冠状病毒已知会导致人类和动物的各种全身感染,这些感染在性质上大多是轻微的。然而,近年来由冠状病毒引起的重大大流行具有很强的侵袭性和毒性。最近的 SARS-CoV2 是冠状病毒大流行中的一个新成员。因此,本研究旨在系统地回顾 SARS-CoV2 阳性患者中枢神经系统受累及其表现。对 2019 年 12 月 1 日至 2020 年 7 月 31 日期间发表的文章进行了系统综述,通过基于网络的 MEDLINE(PubMed)和 Google Scholar 数据库,使用以下关键字进行搜索:"COVID-19" 或 "冠状病毒" 或 "SARS-CoV2" 和 "神经" 或 "中枢神经系统" 或 "大脑"。通过系统综述的步骤,选择了 8 篇文章进行定性分析。这些文章大多报告了在不同病房住院的患者的神经系统症状以及其他一般症状。没有一项研究专门研究 SARS-CoV2 阳性患者的神经系统表现和并发症。本研究得出的结论是,缺乏质量好的研究来试图确定 SARS-CoV2 感染在中枢神经系统及其表现中的作用。然而,有证据表明,中枢神经系统受累在大多数患者中存在。对这些感染进行适当的记录,并将其识别为轻度、中度和重度感染,将有助于早期识别和治疗这些患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c155/7986314/d0d73ac32f8f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c155/7986314/d0d73ac32f8f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c155/7986314/d0d73ac32f8f/gr1_lrg.jpg

相似文献

1
Systemic review of CNS involvement and its manifestations in SARS-CoV2 positive patients.对 SARS-CoV2 阳性患者中枢神经系统受累及其表现的系统评价。
J Infect Public Health. 2021 Jun;14(6):734-739. doi: 10.1016/j.jiph.2021.03.005. Epub 2021 Mar 23.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Systemic corticosteroids for the treatment of COVID-19.全身性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963.
6
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
7
Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.长期护理机构中实施的非药物措施以预防 SARS-CoV-2 感染及其后果:快速综述。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2.
8
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3.
9
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
10
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.

引用本文的文献

1
microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary.微小RNA的异质性、先天免疫防御与新型冠状病毒2感染的效力——一篇评论
Noncoding RNA. 2021 Jun 18;7(2):37. doi: 10.3390/ncrna7020037.

本文引用的文献

1
Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome.长新冠患者的不良结局:慢性新冠综合征中 SARS-CoV-2 对中枢神经系统的影响。
ACS Chem Neurosci. 2020 Dec 16;11(24):4017-4020. doi: 10.1021/acschemneuro.0c00725. Epub 2020 Dec 4.
2
Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers.慢性新冠综合征:需要为长期新冠和新冠长期康复者确定合适的医学术语。
J Med Virol. 2021 May;93(5):2555-2556. doi: 10.1002/jmv.26624. Epub 2021 Mar 1.
3
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.
新型冠状病毒肺炎后急性脑血管病:一项单中心、回顾性、观察性研究。
Stroke Vasc Neurol. 2020 Sep;5(3):279-284. doi: 10.1136/svn-2020-000431. Epub 2020 Jul 2.
4
Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.COVID-19 相关谵妄:一项病例系列研究及对中枢神经系统受累潜在机制的探索。
Gen Hosp Psychiatry. 2020 Jul-Aug;65:47-53. doi: 10.1016/j.genhosppsych.2020.05.008. Epub 2020 May 22.
5
Macrothrombosis and stroke in patients with mild Covid-19 infection.轻度新冠病毒感染患者的巨栓形成与卒中。
J Thromb Haemost. 2020 Aug;18(8):2031-2033. doi: 10.1111/jth.14938. Epub 2020 Jun 25.
6
Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.新型冠状病毒肺炎患者急性嗅觉或味觉丧失的流行率和持续时间。
J Korean Med Sci. 2020 May 11;35(18):e174. doi: 10.3346/jkms.2020.35.e174.
7
Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.两名患有急性脑膜脑炎并伴有新型冠状病毒2019感染的患者。
Eur J Neurol. 2020 Sep;27(9):e43-e44. doi: 10.1111/ene.14298. Epub 2020 May 30.
8
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.我们应该在 COVID-19 中刺激还是抑制免疫反应?细胞因子和抗细胞因子干预。
Autoimmun Rev. 2020 Jul;19(7):102567. doi: 10.1016/j.autrev.2020.102567. Epub 2020 May 4.
9
Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study.COVID-19 大流行期间新发嗅觉丧失后的早期康复 - 一项观察性队列研究。
J Otolaryngol Head Neck Surg. 2020 May 4;49(1):26. doi: 10.1186/s40463-020-00423-8.
10
Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke.COVID-19 患者和卒中患者脑脊液中 SARS-CoV-2 的状况。
J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):846-848. doi: 10.1136/jnnp-2020-323522. Epub 2020 Apr 30.